Impact of COVID-19 on Mental Health in Peru

Authors

  • Juan Francisco Rivera Feijoo Universidad Nacional Mayor de San Marcos

DOI:

https://doi.org/10.14422/rib.i21.y2023.004

Keywords:

Peru, COVID-19, lethality and sequelae in mental health

Abstract

In Peru, COVID-19 produced the highest mortality rate in the world, with important negative effects on patients, their families and their cities. The altered state of mental health has been observed as reported worldwide. According to epidemiological estimates in several parts of the world, there was an increase in anxiety disorders and depressive disorders very close to 30%. The country was already in a very fragile situation regarding health requirements and now it has even more cases to attend to. If anxiety and depression are not treated, they become persistent and lead to disability. We describe the most significant biological clinical pictures to explain why they did not increase. The relationship is illustrated by a clinical picture that also shows the frequent phenomenon of comorbidity in mental health care. We have contextualized events around the world and other mental health conditions less aggravated by the pandemic.

Downloads

Download data is not yet available.

References

Asociación Americana de Psiquiatría. (2014). Manual diagnóstico y estadístico de los trastornos mentales (DSM-5) (5.ª ed.). Asociación Americana de Psiquiatría.

Cutipé, Y. (2022, 9 de septiembre). La salud mental y la respuesta en el estado del estado peruano. Conferencia.

El Comercio. (2022, 22 de diciembre). Consumo de alcohol en la pandemia. Lima.

Fond, G., Nemani, K., Etchecopar-Etchart, D., Loundou, A. Goff, D. C., Lee, S. W., Lancon, S., Auquier, P., Baumstarck, K., Llorca, P.-M., Yon, D. K. y Boyer, L. (2021). Association between mental health disorders and mortality among patients with COVID-19 in 7 Countries. A Systematic Review and Meta-analysis. JAMA Psychiatry, 78(11), 1208-1217. https://doi.org/10.1001/jamapsychiatry.2021.2274

Instituto de Sanimetría y Evaluación Sanitaria. (2022). Global Health Data Exchange (GHDx). https://vizhub.healthdata.org/gbd-results/

Halabe, J., Robledo, Z. y Fajardo, G. (eds.). (2022). Síndrome post-COVID-19. Certezas e interrogantes. Panamericana.

Malhi, G. y Mann, J. (2018). Depression. The Lancet, 392(10161), 2299-2312. https://doi.org/10.1016/S0140-6736(18)31948-2

Msemburi W., Karlinsky A, Knutson V., Aleshin-Guendel, S., Chatterji, S. y Wakefield, J. (2022). The WHO estimates of excess mortality associated with the COVID-19 pandemic. Nature, (613), 130-137. https://doi.org/10.1038/s41586-022-05522-2

Noh, C. S., Kim, W. Y. y Baek, M. S. (2021). Risk factors associated with the need for oxygen therapy in patients with COVID-19. Medicine, 100(18), e25819. https://doi.org/10.1097/md.0000000000025819

Organización Mundial de la Salud. (2020a). Estimaciones de salud mental. https://www.paho.org/es/enlace/causas-principales-mortalidad-discapacidad

Organización Mundial de la Salud. (2020b). Demencia. https://www.who.int/es/news-room/fact-sheets/detail/dementia

Organización Mundial de la Salud. (2021). Depression. https://www.who.int/news-room/fact-sheets/detail/depression

Organización Mundial de la Salud. (2022a). COVID-19 pandemic triggers 25% increase in prevalence of anxiety and depression worldwide.

Organización Mundial de la Salud. (2022b). Alcohol. https://www.who.int/news-room/fact-sheets/detail/alcohol

Organización Mundial de la Salud. (2022c). Salud mental y COVID-19: datos iniciales sobre las repercusiones de la pandemia. https://www.who.int/es/publications/i/item/WHO-2019-nCoV-Sci_Brief-Mental_health-2022.1

Ostyerholm, M. y Olshaker, M. (2020). La amenaza más letal. Nuestra guerra contra las pandemias y cómo evitar la próxima. Planeta.

Rondón, M. (2022). Entrevista radial en octubre a propósito de un caso de pseudociesis y la necesidad de respetar la privacidad de información en las pacientes.

Saavedra, J., Aliaga, K., Castillo-Martel, W., Huamán Pineda, J., Luna Solís, Y., Nicolás Hoyos, Y., Krüger Malpartida, H., Paz Schaeffer, V., Robles Arana, Y., Sagástegui Soto, A. A. I., Sarabia Arce, S., Vega Dienstmaier, J. M. y Zevallos Bustamante, S. (2022). Estudio epidemiológico sobre el impacto de la pandemia COVID-19 en la salud mental de la población de Lima Metropolitana. Diagnóstico, 61(3), e374. https://doi.org/10.33734/diagnostico.v61i3.374

Solmi, M., Radua, J., Olivola, M., Croce, E., Soardo, L., Salazar de Pablo, G., Shin, J. I., Kirkbride, J. B., Jones, P., Kim, J. H., Kim, J. Y., Carvalho, A. F., Seeman, M. V., Correll, C. U. y Fusar-Poli, P. (2021). Age at onset of mental disorders worldwide: large-scale metaanalysis of 192 epidemiological studies. Molecular Psychiatry, 27, 281-295. https://doi.org/10.1038/s41380-021-01161-7

Steel, Z., Marnane, C., Iranpour, C., Chey, T., Jackson, J. W., Patel, V. y Silove, D. (2014). The global prevalence of common mental disorders: a systematic review and meta-analysis 1980–2013. International Journal of Epidemiology, 43(2), 476-493. https://doi.org/10.1093/ije/dyu038

Valdez, R., Basombrío, C. y Vera, D. (2021). Las economías criminales y su impacto en el Perú. ¿Cuáles? ¿Cuánto? ¿Dónde? ¿Cómo? Capital Humano y Social S.A.

Warren, N., Kisely, S. y Siskind, D. (2021). Maximizing the Uptake of a COVID-19 Vaccine in People with Severe Mental Illness: A Public Health Priority. JAMA Psychiatry, 78(6), 589-590. https://doi.org/10.1001/jamapsychiatry.2020.4396

Watson, J., Barnsley, O., Toor, J., Hogan, A., Winskill, P. y Ghani, A. (2022). Global impact of the first year of COVID-19 vaccination: a mathematical modelling study. The Lancet Infectious disease, 22(9), 1293- 1302. https://doi.org/10.1016/S1473-3099(22)00320-6

salud mental y COVID-19

Published

2023-03-14

How to Cite

Rivera Feijoo, J. F. (2023). Impact of COVID-19 on Mental Health in Peru. Revista Iberoamericana De Bioética, (21), 1–18. https://doi.org/10.14422/rib.i21.y2023.004